A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo.

Diepstraten ST, Deng Y, Potts MA, Heidersbach A, König C, Dorighi KM, Tai L, Kueh AJ, Whelan L, Chang C, Brown F, Kelly GL, Fortin JP, Haley B, La Marca JE, Herold MJ.

Open source

DOI: 10.1126/sciadv.aec0722
Published: 2026-09-18
Container: Sci Adv
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/sciadv.aec0722,
  title = {A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo.},
  author = {Diepstraten ST and  Deng Y and  Potts MA and  Heidersbach A and  König C and  Dorighi KM and  Tai L and  Kueh AJ and  Whelan L and  Chang C and  Brown F and  Kelly GL and  Fortin JP and  Haley B and  La Marca JE and  Herold MJ.},
  year = {2026},
  journal = {Sci Adv},
  doi = {10.1126/sciadv.aec0722},
  url = {https://doi.org/10.1126/sciadv.aec0722}
}

RIS

TY  - JOUR
TI  - A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo.
AU  - Diepstraten ST
AU  -  Deng Y
AU  -  Potts MA
AU  -  Heidersbach A
AU  -  König C
AU  -  Dorighi KM
AU  -  Tai L
AU  -  Kueh AJ
AU  -  Whelan L
AU  -  Chang C
AU  -  Brown F
AU  -  Kelly GL
AU  -  Fortin JP
AU  -  Haley B
AU  -  La Marca JE
AU  -  Herold MJ.
PY  - 2026
JO  - Sci Adv
DO  - 10.1126/sciadv.aec0722
UR  - https://doi.org/10.1126/sciadv.aec0722
ER  -

APA

ST, D., Y, D., MA, P., A, H., C, K., KM, D., L, T., AJ, K., L, W., C, C., F, B., GL, K., JP, F., B, H., JE, L. M., & MJ., H. (2026). A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo.. Sci Adv. https://doi.org/10.1126/sciadv.aec0722

Source records

europe-pmc · retrieved 2026-09-25T21:55:24.448Z